Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GLMD Galmed Pharmaceuticals Ltd

0,3983

-0,0167 (-4,02%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Galmed Pharmaceuticals Charts.

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Galmed Pharmaceuticals Charts.

News Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
Donnerstag 4 April 2024 (1 Monat vor) • PR Newswire (US)

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
Freitag 15 März 2024 (2 Monate vor) • PR Newswire (US)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Montag 12 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 30 November 2023 (5 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 20 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Montag 20 November 2023 (6 Monate vor) • PR Newswire (US)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 1 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 26 September 2023 (7 Monate vor) • Edgar (US Regulatory)

Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
Dienstag 26 September 2023 (7 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 22 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Weitere Galmed Pharmaceuticals Ltd News-Artikel

Health Care Select Sector

Deutsche Lufthansa

Deutsche Telekom (QX)

Financial Select Sector

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen